These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10453916

  • 1. The perception of teratogenic risk by women with nausea and vomiting of pregnancy.
    Mazzotta P, Magee LA, Maltepe C, Lifshitz A, Navioz Y, Koren G.
    Reprod Toxicol; 1999; 13(4):313-9. PubMed ID: 10453916
    [Abstract] [Full Text] [Related]

  • 2. Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy.
    Mazzotta P, Stewart D, Atanackovic G, Koren G, Magee LA.
    J Psychosom Obstet Gynaecol; 2000 Sep; 21(3):129-36. PubMed ID: 11076334
    [Abstract] [Full Text] [Related]

  • 3. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.
    Mazzotta P, Magee LA.
    Drugs; 2000 Apr; 59(4):781-800. PubMed ID: 10804035
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A RCT of psychotherapy in women with nausea and vomiting of pregnancy.
    Faramarzi M, Yazdani S, Barat S.
    Hum Reprod; 2015 Dec; 30(12):2764-73. PubMed ID: 26466913
    [Abstract] [Full Text] [Related]

  • 6. Nausea and vomiting of pregnancy: prevalence, severity and relation to psychosocial health.
    Kramer J, Bowen A, Stewart N, Muhajarine N.
    MCN Am J Matern Child Nurs; 2013 Dec; 38(1):21-7. PubMed ID: 23232775
    [Abstract] [Full Text] [Related]

  • 7. The safety of drugs for the treatment of nausea and vomiting of pregnancy.
    Gill SK, Einarson A.
    Expert Opin Drug Saf; 2007 Nov; 6(6):685-94. PubMed ID: 17967157
    [Abstract] [Full Text] [Related]

  • 8. Safety considerations surrounding use of treatment options for nausea and vomiting in pregnancy.
    Koren G.
    Expert Opin Drug Saf; 2017 Nov; 16(11):1227-1234. PubMed ID: 28749713
    [Abstract] [Full Text] [Related]

  • 9. Delivery outcome after the use of meclozine in early pregnancy.
    Källén B, Mottet I.
    Eur J Epidemiol; 2003 Nov; 18(7):665-9. PubMed ID: 12952140
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP).
    Magee LA, Mazzotta P, Koren G.
    Am J Obstet Gynecol; 2002 May; 186(5 Suppl Understanding):S256-61. PubMed ID: 12011897
    [Abstract] [Full Text] [Related]

  • 12. Determinants of women's decision making on whether to treat nausea and vomiting of pregnancy pharmacologically.
    Baggley A, Navioz Y, Maltepe C, Koren G, Einarson A.
    J Midwifery Womens Health; 2004 May; 49(4):350-4. PubMed ID: 15236716
    [Abstract] [Full Text] [Related]

  • 13. The pharmacologic management of nausea and vomiting of pregnancy.
    Niebyl JR, Briggs GG.
    J Fam Pract; 2014 Feb; 63(2 Suppl):S31-7. PubMed ID: 24527483
    [Abstract] [Full Text] [Related]

  • 14. Medical, social, and legal implications of treating nausea and vomiting of pregnancy.
    Brent R.
    Am J Obstet Gynecol; 2002 May; 186(5 Suppl Understanding):S262-6. PubMed ID: 12011898
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy.
    Leathem AM.
    Clin Pharm; 1986 Aug; 5(8):660-8. PubMed ID: 2874910
    [Abstract] [Full Text] [Related]

  • 16. Is vomiting during pregnancy teratogenic?
    Klebanoff MA, Mills JL.
    Br Med J (Clin Res Ed); 1986 Mar 15; 292(6522):724-6. PubMed ID: 3082411
    [Abstract] [Full Text] [Related]

  • 17. Treatment of nausea and vomiting during pregnancy -a cross-sectional study among 712 Norwegian women.
    Heitmann K, Solheimsnes A, Havnen GC, Nordeng H, Holst L.
    Eur J Clin Pharmacol; 2016 May 15; 72(5):593-604. PubMed ID: 26815908
    [Abstract] [Full Text] [Related]

  • 18. Bendectin and birth defects. II: Ecological analyses.
    Kutcher JS, Engle A, Firth J, Lamm SH.
    Birth Defects Res A Clin Mol Teratol; 2003 Feb 15; 67(2):88-97. PubMed ID: 12769504
    [Abstract] [Full Text] [Related]

  • 19. Determinants of the need for hospital care among women with nausea and vomiting of pregnancy.
    Atanackovic G, Wolpin J, Koren G.
    Clin Invest Med; 2001 Apr 15; 24(2):90-3. PubMed ID: 11368151
    [Abstract] [Full Text] [Related]

  • 20. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.
    Anderka M, Mitchell AA, Louik C, Werler MM, Hernández-Diaz S, Rasmussen SA, National Birth Defects Prevention Study.
    Birth Defects Res A Clin Mol Teratol; 2012 Jan 15; 94(1):22-30. PubMed ID: 22102545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.